Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Melanocytes are important for skin and hair color and protect the skin from UV damage.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Researchers found four genes that could help diagnose severe alopecia areata early.

The research reveals how early embryonic mouse skin develops from simple to complex structures, identifying various cell types and their roles in this process.

Blocking Rab27a slows hair growth, while blocking Rab27b encourages it.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

The conclusion is that analyzing RNA from skin oils is a promising way to understand skin diseases.

Hairless mammals have genetic changes in both their protein-coding and regulatory sequences related to hair.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Erdr1 could be a new marker for diagnosing hair loss.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

Pantethine may boost the immune system's ability to fight sarcoma.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Skin cell types develop when specific genes are turned on by removing certain chemical tags from DNA.

Apremilast shows promise for several skin conditions but needs more research.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Fzd2 is important for skin and hair development through various signaling ways.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Stopping S100A3 activity slows down hair growth in mice.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Helminth protein helps wounds heal better by reducing scarring and promoting tissue growth.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.